398 related articles for article (PubMed ID: 17090722)
1. Differentiation of the gastric mucosa III. Animal models of oxyntic atrophy and metaplasia.
Goldenring JR; Nomura S
Am J Physiol Gastrointest Liver Physiol; 2006 Dec; 291(6):G999-1004. PubMed ID: 17090722
[TBL] [Abstract][Full Text] [Related]
2. Altered metaplastic response of waved-2 EGF receptor mutant mice to acute oxyntic atrophy.
Ogawa M; Nomura S; Varro A; Wang TC; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G793-804. PubMed ID: 16306133
[TBL] [Abstract][Full Text] [Related]
3. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss.
Nozaki K; Ogawa M; Williams JA; Lafleur BJ; Ng V; Drapkin RI; Mills JC; Konieczny SF; Nomura S; Goldenring JR
Gastroenterology; 2008 Feb; 134(2):511-22. PubMed ID: 18242217
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of oxyntic atrophy-induced gastric metaplasia in amphiregulin-deficient mice.
Nam KT; Varro A; Coffey RJ; Goldenring JR
Gastroenterology; 2007 May; 132(5):1804-19. PubMed ID: 17484876
[TBL] [Abstract][Full Text] [Related]
5. Spasmolytic polypeptide-expressing metaplasia (SPEM) in the gastric oxyntic mucosa does not arise from Lgr5-expressing cells.
Nam KT; O'Neal RL; Coffey RJ; Finke PE; Barker N; Goldenring JR
Gut; 2012 Dec; 61(12):1678-85. PubMed ID: 22198711
[TBL] [Abstract][Full Text] [Related]
6. Oxyntic atrophy, metaplasia, and gastric cancer.
Goldenring JR; Nam KT
Prog Mol Biol Transl Sci; 2010; 96():117-31. PubMed ID: 21075342
[TBL] [Abstract][Full Text] [Related]
7. Current understanding of SPEM and its standing in the preneoplastic process.
Weis VG; Goldenring JR
Gastric Cancer; 2009; 12(4):189-97. PubMed ID: 20047123
[TBL] [Abstract][Full Text] [Related]
8. Alterations in gastric mucosal lineages induced by acute oxyntic atrophy in wild-type and gastrin-deficient mice.
Nomura S; Yamaguchi H; Ogawa M; Wang TC; Lee JR; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G362-75. PubMed ID: 15647607
[TBL] [Abstract][Full Text] [Related]
9. Association of spasmolytic polypeptide-expressing metaplasia with carcinogen administration and oxyntic atrophy in rats.
Yamaguchi H; Goldenring JR; Kaminishi M; Lee JR
Lab Invest; 2002 Aug; 82(8):1045-52. PubMed ID: 12177243
[TBL] [Abstract][Full Text] [Related]
10. Macrophages promote progression of spasmolytic polypeptide-expressing metaplasia after acute loss of parietal cells.
Petersen CP; Weis VG; Nam KT; Sousa JF; Fingleton B; Goldenring JR
Gastroenterology; 2014 Jun; 146(7):1727-38.e8. PubMed ID: 24534633
[TBL] [Abstract][Full Text] [Related]
11. Maturity and age influence chief cell ability to transdifferentiate into metaplasia.
Weis VG; Petersen CP; Weis JA; Meyer AR; Choi E; Mills JC; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2017 Jan; 312(1):G67-G76. PubMed ID: 27881402
[TBL] [Abstract][Full Text] [Related]
12. Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia.
Nam KT; Lee HJ; Mok H; Romero-Gallo J; Crowe JE; Peek RM; Goldenring JR
Gastroenterology; 2009 Apr; 136(4):1288-96. PubMed ID: 19230855
[TBL] [Abstract][Full Text] [Related]
13. Decrease in MiR-148a Expression During Initiation of Chief Cell Transdifferentiation.
Shimizu T; Sohn Y; Choi E; Petersen CP; Prasad N; Goldenring JR
Cell Mol Gastroenterol Hepatol; 2020; 9(1):61-78. PubMed ID: 31473306
[TBL] [Abstract][Full Text] [Related]
14. Mature chief cells are cryptic progenitors for metaplasia in the stomach.
Nam KT; Lee HJ; Sousa JF; Weis VG; O'Neal RL; Finke PE; Romero-Gallo J; Shi G; Mills JC; Peek RM; Konieczny SF; Goldenring JR
Gastroenterology; 2010 Dec; 139(6):2028-2037.e9. PubMed ID: 20854822
[TBL] [Abstract][Full Text] [Related]
15. Carcinogenesis of Helicobacter pylori.
Correa P; Houghton J
Gastroenterology; 2007 Aug; 133(2):659-72. PubMed ID: 17681184
[TBL] [Abstract][Full Text] [Related]
16. Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma.
Schmidt PH; Lee JR; Joshi V; Playford RJ; Poulsom R; Wright NA; Goldenring JR
Lab Invest; 1999 Jun; 79(6):639-46. PubMed ID: 10378506
[TBL] [Abstract][Full Text] [Related]
17. The cytoprotective protein clusterin is overexpressed in hypergastrinemic rodent models of oxyntic preneoplasia and promotes gastric cancer cell survival.
Vange P; Bruland T; Doseth B; Fossmark R; Sousa MML; Beisvag V; Sørdal Ø; Qvigstad G; Waldum HL; Sandvik AK; Bakke I
PLoS One; 2017; 12(9):e0184514. PubMed ID: 28902909
[TBL] [Abstract][Full Text] [Related]
18. Interferon-γ directly induces gastric epithelial cell death and is required for progression to metaplasia.
Osaki LH; Bockerstett KA; Wong CF; Ford EL; Madison BB; DiPaolo RJ; Mills JC
J Pathol; 2019 Apr; 247(4):513-523. PubMed ID: 30511397
[TBL] [Abstract][Full Text] [Related]
19. WFDC2 Promotes Spasmolytic Polypeptide-Expressing Metaplasia Through the Up-Regulation of IL33 in Response to Injury.
Jeong H; Lee B; Kim KH; Cho SY; Cho Y; Park J; Lee Y; Oh Y; Hwang BR; Jang AR; Park JH; Park JH; Jeong SH; Lee D; Lee YC; Lim KM; Goldenring JR; Nam KT
Gastroenterology; 2021 Sep; 161(3):953-967.e15. PubMed ID: 34116028
[TBL] [Abstract][Full Text] [Related]
20. Omeprazole treatment ameliorates oxyntic atrophy induced by DMP-777.
Ogawa M; Nomura S; Car BD; Goldenring JR
Dig Dis Sci; 2006 Mar; 51(3):431-9. PubMed ID: 16614949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
